National HealthCare is delivering robust earnings growth, with EBITDA projected to grow 46.1%. Read why I reiterate my buy ...

Lowe's recent M&A activity has paused buybacks and pushed leverage to 3.4x, above target. See why LOW stock is a Sell.

Cohen & Steers maintains strong fund performance, with 95% of funds beating benchmarks across all major timeframes. See why ...

Direxion Daily Gold Miners Bear 2X Shares is positioned as a short-term trading hedge, not a long-term investment. See why ...

Envista's FY25 earnings are likely to exceed the consensus estimates. Click here to read why NVST stock is upgraded to Buy.

Prediction markets surge to 80% odds of a US government shutdown by Jan 31 as Democrats block $1.2T DHS funding; track key ...

Spot gold ( XAUUSD:CUR) rose 0.8% to $5,028, building on an 8.5% gain last week. A weaker dollar ( DXY) reinforced demand, ...

Dividends ensure accounting honesty, and diversifying across 42+ holdings using preferred equity and bonds protects your ...

The Nasdaq and S&P 500 may remain flat in 2026 unless mega-cap 'Trillionaires' regain momentum. Read more about the market ...

Meritage Homes is dealing with issues like all the other players but is well-positioned to thrive eventually. Read why MTH ...

Baillie Gifford’s Q4 2025 13F portfolio fell from ~$135B to ~$120B. Read more about the significant stake increases and major ...

Carlisle Companies is well-positioned to benefit from a projected rebound in U.S. residential construction. Read why CSL ...